1) Renal cell carcinoma arises from renal tubular cells and is the most common neoplasm of the kidneys.
2) It typically presents as a yellowish or dull white semi-transparent mass with areas of hemorrhage on the cut surface and can spread locally to the renal vein or distantly to bones and lungs.
3) Investigations include blood tests, imaging like ultrasound and CT scan to determine staging according to TNM classification, while treatment involves nephrectomy, with partial or complete removal of the kidney and ureter.
1) Renal cell carcinoma arises from renal tubular cells and is the most common neoplasm of the kidneys.
2) It typically presents as a yellowish or dull white semi-transparent mass with areas of hemorrhage on the cut surface and can spread locally to the renal vein or distantly to bones and lungs.
3) Investigations include blood tests, imaging like ultrasound and CT scan to determine staging according to TNM classification, while treatment involves nephrectomy, with partial or complete removal of the kidney and ureter.
1) Renal cell carcinoma arises from renal tubular cells and is the most common neoplasm of the kidneys.
2) It typically presents as a yellowish or dull white semi-transparent mass with areas of hemorrhage on the cut surface and can spread locally to the renal vein or distantly to bones and lungs.
3) Investigations include blood tests, imaging like ultrasound and CT scan to determine staging according to TNM classification, while treatment involves nephrectomy, with partial or complete removal of the kidney and ureter.
1) Renal cell carcinoma arises from renal tubular cells and is the most common neoplasm of the kidneys.
2) It typically presents as a yellowish or dull white semi-transparent mass with areas of hemorrhage on the cut surface and can spread locally to the renal vein or distantly to bones and lungs.
3) Investigations include blood tests, imaging like ultrasound and CT scan to determine staging according to TNM classification, while treatment involves nephrectomy, with partial or complete removal of the kidney and ureter.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 10
RENAL CELL
CARCINOMA (Hydronephroma=Grawitz’s tumour)
‘ASYURA BINTI MOHD. REZA
INTRODUCTION • Adenocarcinoma • The most common neoplasm of kidneys (75%) • Arises from renal tubular cells • Common in men PATHOLOGY
1) The cut surface : usually yellowish/dull white, semi-transparent with
areas of hemorrhage. 2) Tumour is often divided into lobules, some are cystic. 3) Larger tumour : irregular in shape with central hemorrhage and necrosis. MODE OF SPREAD • Local spread: renal vein • Distant spread : bone • Hematogenous spread : through inferior vena cava lungs (Cannonball appearance) • Lymphatic spread : para aortic lymph nodes and beyond (only when the tumor breach Gerato’s fascia) CLINICAL FEATURES • Asymptomatic in the beginning • Triad of loin pain, loin mass & hematuria (10%) indicate advanced disease • Hematuria : the most common complaint • Left vericocele when tumour spread to left renal vein • Metastases symptoms : bone pain, chronic cough, hemoptysis • Atypical symptoms : persistent fever, cachexia, anaemia, polycythaemia, hypertension, nephrotic syndrome STAGING INVESTIGATIONS INITIAL TEST TEST REASON Full blood count Anaemia, polycythaemia Renal profile Assess remaining renal function ESR Increased in RCC Serum calcium Hypercalcaemia (Paraneoplastic syndrome) Coagulation Pre-surgery investigation profile Liver function - Impaired in metastases or test Paraneoplastic syndrome - ALP increase in bone metastases
TEST TO CONFIRM DIAGNOSIS & STAGING TEST REASON Transabdominal ultrasound - To look for origin of mass, cystic/solid - Sign of metastases in liver and lymph node enlargement Contrast CT scan of abdomen - For TNM staging - Demonstrate the extent of lesion MRI of abdomen If renal function is impaired in order to permit contrast Transesophageal If suspected spread of tumour from IVC echocardiogram involving right atrium Excretory urography Able to assess renal function and any filling defect indicating presence of mass PET scan Most sensitive but not widely available TREATMENT • RCC responds poorly to radiotherapy or conventional chemotherapy. • Immunotherapy of cytokine IL-2 shows some benefits but still not widely recommended.
Mainstay of treatment : Nephrectomy
Partial/ complete nephrectomy and removal of ureter and a cuff of bladder Types of approach: - loin - transabdominal PROGNOSIS • 70% of patients : well after 3 years post- nephrectomy • 60% of patients : well after 5 years post- nephrectomy